PDF herunterladen
Planta Med 2023; 89(15): 1483-1492
DOI: 10.1055/a-2156-4653
Biological and Pharmacological Activity
Original Papers

Immulina as an Immunostimulatory Supplement: Formulation and Pharmacological Studies

Yusheng Li‡
1   Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA
,
Nan Ji‡
1   Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA
,
Minia Wang‡
1   Department of Pharmaceutics and Drug Delivery, University of Mississippi, University, Mississippi, USA
,
Nirmal D. Pugh
2   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA
,
Ikhlas A. Khan
2   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA
3   Department of BioMolecular Sciences, University of Mississippi, University, Mississippi, USA
,
Chalet Tan 
4   Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA
› InstitutsangabenThis work was supported by the Office of Dietary Supplements and the National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health [U19AT010838].
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Immulina is a commercially available extract of Arthrospira platensis enriched with bacterial lipoproteins that acts as a potent Toll-like receptor 2 agonist. However, the immunostimulatory effect of Immulina is not well understood in vivo. Here, to devise an Immulina formulation suitable for in vivo oral gavage dosing, Immulina nanosuspension was prepared and freeze-dried to yield lyophilized nano-Immulina, which had an average particle size of around 300 nm and fully retained the bioactivity as a Toll-like receptor 2 agonist. Compared to the regular Immulina powder, lyophilized nano-Immulina notably accelerated the dissolution in aqueous media. Immulina nanosuspension was found to stimulate the production of proinflammatory cytokines in murine bone marrow-derived dendritic cells and macrophages. The immune response to Immulina was investigated in healthy mice by longitudinally monitoring the phagocytic activity of circulating neutrophils as a surrogate marker. Following daily oral ingestion of Immulina nanosuspension (10 mg/mouse/day), the phagocytic activity of circulating neutrophils was significantly elevated, suggesting an important mechanism for Immulina to enhance innate immunity.

Key words

Arthrospira platensis - Phormidiaceae - Immulina - TLR2 - dissolution - neutrophil - phagocytosis

Supporting Information

    Information on the physical appearance of Immulina formulations, the purity of murine BMMs and BMDCs, the gating strategy for the flow cytometry analysis on circulating neutrophils, the immunophenotypic analysis on leukocytes in heparinized whole blood, and the primer sequences for qPCR analysis is available as Supporting Information.

  • Ergänzendes Material


Publikationsverlauf

Eingereicht: 28. April 2023

Angenommen nach Revision: 11. August 2023

Artikel online veröffentlicht:
30. August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ciferri O. Spirulina, the edible microorganism. Microbiol Rev 1983; 47: 551-578
    CrossrefPubMedGoogle Scholar
  • 2 Calella P, Cerullo G, Di Dio M, Liguori F, Di Onofrio V, Gallè F, Liguori G. Antioxidant, anti-inflammatory and immunomodulatory effects of spirulina in exercise and sport: A systematic review. Front Nutr 2022; 9: 1048258
    CrossrefPubMedGoogle Scholar
  • 3 Gogna S, Kaur J, Sharma K, Prasad R, Singh J, Bhadariya V, Kumar P, Jarial S. Spirulina – An edible cyanobacterium with potential therapeutic health benefits and toxicological consequences. J Am Nutr Assoc 2023; 42: 559-572
    PubMedGoogle Scholar
  • 4 Fais G, Manca A, Bolognesi F, Borselli M, Concas A, Busutti M, Broggi G, Sanna P, Castillo-Aleman YM, Rivero-Jiménez RA. Wide range applications of Spirulina: From earth to SPACE missions. Mar Drugs 2022; 20: 299
    CrossrefPubMedGoogle Scholar
  • 5 Jester BW, Zhao H, Gewe M, Adame T, Perruzza L, Bolick DT, Agosti J, Khuong N, Kuestner R, Gamble C. Development of Spirulina for the manufacture and oral delivery of protein therapeutics. Nat Biotechnol 2022; 40: 956-964
    CrossrefPubMedGoogle Scholar
  • 6 Pasco DS, Pugh ND, Elsohly M, Ross S, ElSohly NM. Potent immunostimulants from microalgae. US Patent 7 205 284, 2007
    PubMedGoogle Scholar
  • 7 Nielsen CH, Balachandran P, Christensen O, Pugh ND, Tamta H, Sufka KJ, Wu X, Walsted A, Schjørring-Thyssen M, Enevold C. Enhancement of natural killer cell activity in healthy subjects by Immulina®, a Spirulina extract enriched for Braun-type lipoproteins. Planta Med 2010; 76: 1802-1808
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 8 Balachandran P, Pugh ND, Ma G, Pasco DS. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int Immunopharmacol 2006; 6: 1808-1814
    CrossrefPubMedGoogle Scholar
  • 9 Huh J, Zhang J, Hauerová R, Lee J, Haider S, Wang M, Hauer T, Khan IA, Chittiboyina AG, Pugh ND. Utility of fatty acid profile and in vitro immune cell activation for chemical and biological standardization of Arthrospira/Limnospira . Sci Rep 2022; 12: 1-13
    CrossrefPubMedGoogle Scholar
  • 10 Pugh ND, Edwall D, Lindmark L, Kousoulas KG, Iyer AV, Haron MH, Pasco DS. Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection. Phytomedicine 2015; 22: 271-276
    CrossrefPubMedGoogle Scholar
  • 11 Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 2021; 6: 291
    CrossrefPubMedGoogle Scholar
  • 12 Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell 2020; 180: 1044-1066
    CrossrefPubMedGoogle Scholar
  • 13 Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1–TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130: 1071-1082
    CrossrefPubMedGoogle Scholar
  • 14 Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009; 31: 873-884
    CrossrefPubMedGoogle Scholar
  • 15 Kaur A, Baldwin J, Brar D, Salunke DB, Petrovsky N. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. Curr Opin Chem Biol 2022; 70: 102172
    CrossrefPubMedGoogle Scholar
  • 16 Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y. Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Medicine 2019; 98: e16771
    CrossrefPubMedGoogle Scholar
  • 17 Sun J, Rutherford ST, Silhavy TJ, Huang KC. Physical properties of the bacterial outer membrane. Nat Rev Microbiol 2022; 20: 236-248
    CrossrefPubMedGoogle Scholar
  • 18 Braun V, Rehn K. Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall: The specific effect of trypsin on the membrane structure. Eur J Biochem 1969; 10: 426-438
    CrossrefPubMedGoogle Scholar
  • 19 Chen YH, Chang GK, Kuo SM, Huang SY, Hu IC, Lo YL, Shih SR. Well-tolerated Spirulina extract inhibits influenza virus replication and reduces virus-induced mortality. Sci Rep 2016; 6: 24253
    CrossrefPubMedGoogle Scholar
  • 20 Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by Spirulina: Augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. Int Immunopharmaol 2002; 2: 423-434
    CrossrefPubMedGoogle Scholar
  • 21 Jog R, Burgess DJ. Pharmaceutical amorphous nanoparticles. J Phar Sci 2017; 106: 39-65
    CrossrefPubMedGoogle Scholar
  • 22 Chandler CE, Ernst RK. Bacterial lipids: Powerful modifiers of the innate immune response. F1000Res 2017; 6: F1000 Faculty Rev-1334
    CrossrefPubMedGoogle Scholar
  • 23 McAllister M. Dynamic dissolution: A step closer to predictive dissolution testing?. Mol Pharm 2010; 7: 1374-1387
    CrossrefPubMedGoogle Scholar
  • 24 Doyle SL, OʼNeill LA. Toll-like receptors: From the discovery of NF-κB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006; 72: 1102-1113
    CrossrefPubMedGoogle Scholar
  • 25 Grzanna R, Polotsky A, Phan PV, Pugh N, Pasco D, Frondoza CG. Immolina, a high-molecular-weight polysaccharide fraction of Spirulina, enhances chemokine expression in human monocytic THP-1cells. J Altern Complement Med 2006; 12: 429-435
    CrossrefPubMedGoogle Scholar
  • 26 Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276: 37692-37699
    CrossrefPubMedGoogle Scholar
  • 27 Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: From mechanisms to disease. Ann Rev Immunol 2012; 30: 459-489
    CrossrefPubMedGoogle Scholar
  • 28 Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov 2020; 19: 253-275
    CrossrefPubMedGoogle Scholar
  • 29 Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102: 2660-2669
    CrossrefPubMedGoogle Scholar
  • 30 Aroca-Crevillén A, Adrover JM, Hidalgo A. Circadian features of neutrophil biology. Front Immunol 2020; 11: 576
    CrossrefPubMedGoogle Scholar
  • 31 OʼBrien GC, Wang JH, Redmond HP. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J Immunol 2005; 174: 1020-1026
    CrossrefPubMedGoogle Scholar
  • 32 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014; 14: 667-685
    CrossrefPubMedGoogle Scholar
  • 33 Gustafsson JK, Johansson ME. The role of goblet cells and mucus in intestinal homeostasis. Nat Rev Gastroenterol Hepatol 2022; 19: 785-803
    CrossrefPubMedGoogle Scholar
  • 34 Gustafsson JK, Davis JE, Rappai T, McDonald KG, Kulkarni DH, Knoop KA, Hogan SP, Fitzpatrick JA, Lencer WI, Newberry RD. Intestinal goblet cells sample and deliver lumenal antigens by regulated endocytic uptake and transcytosis. Elife 2021; 10: e67292
    CrossrefPubMedGoogle Scholar
  • 35 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantification PCR and the 2-ΔΔC T method. Methods 2001; 25: 402-408
    CrossrefPubMedGoogle Scholar